Literature DB >> 10692046

Human B-cell lines constitutively express and secrete interleukin-16.

V Sharma1, J L Sparks, J D Vail.   

Abstract

Interleukin-16 (IL-16), produced by activated CD8+ T lymphocytes, is inhibitory to human immunodeficiency virus-1 (HIV-1) replication. In an attempt to determine whether human B cells express and secrete IL-16, a wide panel of B-cell lines derived from patients with acquired immune deficiency syndrome (AIDS)-associated B-cell lymphomas (AABCL) (n = 5) and from non-AABCLs (n = 8) were studied. Using reverse transcription-polymerase chain reaction (RT-PCR) analysis, we were able to observe ubiquitous expression of IL-16 mRNA. Kinetic studies on constitutive mRNA turnover and secretion for IL-16 suggests that the optimum expression is at 24 hr. Interestingly, we report, for the first time, IL-16 secretion by human B-cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692046      PMCID: PMC2327161          DOI: 10.1046/j.1365-2567.2000.00959.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma.

Authors:  S Laberge; P Ernst; O Ghaffar; W W Cruikshank; H Kornfeld; D M Center; Q Hamid
Journal:  Am J Respir Cell Mol Biol       Date:  1997-08       Impact factor: 6.914

2.  Modulation of macrophage inflammatory protein-1alpha and its receptors in human B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma.

Authors:  V Sharma; D Walper; R Deckert
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

3.  Tissue and T cell distribution of precursor and mature IL-16.

Authors:  G L Chupp; E A Wright; D Wu; M Vallen-Mashikian; W W Cruikshank; D M Center; H Kornfeld; J S Berman
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

4.  IL-16 represses HIV-1 promoter activity.

Authors:  J W Maciaszek; N A Parada; W W Cruikshank; D M Center; H Kornfeld; G A Viglianti
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

5.  Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor.

Authors:  M Baier; N Bannert; A Werner; K Lang; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression.

Authors:  P Zhou; S Goldstein; K Devadas; D Tewari; A L Notkins
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

7.  C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.

Authors:  E Scala; G D'Offizi; R Rosso; O Turriziani; R Ferrara; A M Mazzone; G Antonelli; F Aiuti; R Paganelli
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: potential roles in inflammation.

Authors:  W E Biddison; D D Taub; W W Cruikshank; D M Center; E W Connor; K Honma
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

9.  Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.

Authors:  K G Lim; H C Wan; P T Bozza; M B Resnick; D T Wong; W W Cruikshank; H Kornfeld; D M Center; P F Weller
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

10.  Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque.

Authors:  H J Schluesener; K Seid; J Kretzschmar; R Meyermann
Journal:  J Neurosci Res       Date:  1996-06-15       Impact factor: 4.164

View more
  10 in total

1.  Proteolytic cleavage of PDZD2 generates a secreted peptide containing two PDZ domains.

Authors:  Man-Lung Yeung; Tammy S M Tam; Anthony C C Tsang; Kwok-Ming Yao
Journal:  EMBO Rep       Date:  2003-03-14       Impact factor: 8.807

2.  Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines.

Authors:  K Tsukamoto; Y C Huang; W C Dorsey; B Carns; V Sharma
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.

Authors:  Lindsay C Spender; Georgina H Cornish; Alexandra Sullivan; Paul J Farrell
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Constitutive expression of interleukin-18 and interleukin-18 receptor mRNA in tumour derived human B-cell lines.

Authors:  S L Lorey; Y C Huang; V Sharma
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

5.  The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population.

Authors:  Xue Qin; Qiliu Peng; Xiaoxia Lao; Zhiping Chen; Yu Lu; Xianjun Lao; Cuiju Mo; Jingzhe Sui; Junrong Wu; Limin Zhai; Shi Yang; Shan Li; Jinmin Zhao
Journal:  Tumour Biol       Date:  2013-10-08

6.  Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.

Authors:  Seyed Mohammad Hossein Kashfi; Faegheh Behboudi Farahbakhsh; Ehsan Nazemalhosseini Mojarad; Kazem Mashayekhi; Pedram Azimzadeh; Sara Romani; Shaghayegh Derakhshani; Habib Malekpour; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Tumour Biol       Date:  2015-09-07

7.  Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.

Authors:  Daniel P Widney; Dorina Gui; Laura M Popoviciu; Jonathan W Said; Elizabeth C Breen; Xin Huang; Christina M R Kitchen; Juan M Alcantar; Jeffrey B Smith; Roger Detels; Otoniel Martínez-Maza
Journal:  AIDS Res Treat       Date:  2010-08-25

8.  Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.

Authors:  Julia Templin; Djordje Atanackovic; Daniel Hasche; Sabarinath Venniyil Radhakrishnan; Tim Luetkens
Journal:  Oncotarget       Date:  2017-07-25

9.  Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation.

Authors:  Shuai Liu; Zhangmengxue Lei; Jie Li; Liu Wang; Ran Jia; Zhongshun Liu; Congwei Jiang; Ying Gao; Mu Liu; Linlin Kuang; Zhikang Qian; Dongming Zhou; Samuel H Speck; Xiaozhen Liang
Journal:  PLoS Pathog       Date:  2020-07-31       Impact factor: 6.823

10.  Association of functional IL16 polymorphisms with cancer and cardiovascular disease: a meta-analysis.

Authors:  Victor Hugo de Souza; Josiane Bazzo de Alencar; Bruna Tiaki Tiyo; Hugo Vicentin Alves; Evelyn Castillo Lima Vendramini; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Oncotarget       Date:  2020-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.